From: Epstein-Barr virus associated gastric carcinoma: a report from Iran in the last four decades
Variables | EBER+/N1 | (%) | OR2 | 95% CI2 |
---|---|---|---|---|
Gender | Â | Â | Â | Â |
   Female | 1/76 | (1) | 1 | reference |
   Male | 8/188 | (4) | 0.3 | 0.01–2.96 |
 |  | P = 0.595 | ||
Age | Â | Â | Â | Â |
   ≥ 70 | 1/36 | (3) | 1 | reference |
   50–69 | 5/180 | (3) | 0.8 | 0.08–44.62 |
   <50 | 3/54 | (6) | 1.3 | 0.08–81.25 |
 |  | P for trend = 1.0 | ||
Location | Â | Â | Â | Â |
   Upper | 1/71 | (1) | 1 | reference |
   Middle | 5/64 | (8) | 6.0 | 0.1–77.86 |
   Lower | 3/130 | (2) | 1.4 | 0.63–296.7 |
 |  | P for heterogeneity = 1.64 | ||
Histology | Â | Â | Â | Â |
   Diffuse | 8/121 | (7) | 1 | reference |
   Intestinal | 1/152 | (1) | 0.08 | 0.002–0.64 |
 |  | P = 0.009 | ||
Invasion | Â | Â | Â | Â |
   Muscle | 3/33 | (9) | 1 | reference |
   serose | 6/222 | (3) | 3.6 | 0.47–24.03 |
 |  | P = 0.243 |